Skip to main content
Premium Trial:

Request an Annual Quote

Terrapin Promotes Chemoinformatics Staff

Premium

SAN FRANCISCO--The privately held Terrapin Technologies pharmaceutical discovery company made several appointments and promotions that it said reflect progress made in applying Terrapin's proprietary chemoinformatics technology. Hugo Villar was promoted to vice-president, discovery technologies, where he will focus on expanding Terrapin's drug discovery platform; Edgardo Laborde, who established internal combinatorial chemistry capabilities since joining Terrapin in 1997 from Ariad Pharmaceuticals, was promoted to associate director, combinatorial chemistry; Steven Schow, most recently director of chemistry at CV Therapeutics, joined the company as senior director, medicinal chemistry; and Robert Lum, formerly of Arris Pharmaceuticals, will join the company as associate director, medicinal chemistry.

Filed under

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.